Bergur Magnussen

Bergur Magnussen is a PhD student and Clinical Assistant in the Department of Rheumatology at Aalborg University Hospital, Faculty of Medicine, Aalborg University, Denmark. His research integrates clinical rheumatology with epidemiological methods to investigate drug safety and disease complications in autoimmune conditions.

His primary research interests include Rheumatoid Arthritis, Cancer Risk Stratification, and Biological DMARD Safety. He specializes in analyzing real-world data from Danish national registries to assess polyautoimmunity risks, malignancy associations, and treatment outcomes with agents like rituximab and tocilizumab. His methodological focus spans cohort design, registry validation, and pharmacoepidemiology.

Recent publications (2025) demonstrate consistent expertise in registry-based rheumatology research, emphasizing cancer risk prediction, lymphoma outcomes, and data classification methodologies. These studies highlight his dual focus on clinical impact and methodological rigor within autoimmune disease management.

Media coverage of his work on research advocacy ('Du støtter forskningen', 2024) reflects active science communication, with dissemination across news outlets, social media, and academic platforms.